Alprazolam prescribing in Tasmania: a two-fold intervention designed to reduce inappropriate prescribing and concomitant opiate prescription

References

• Webber T. Professional Services Review. Report to the Professions 2007–08. Commonwealth of Australia, Canberra 2009
   Google Scholar
• Miller N, Gold M. Abuse, addiction, tolerance, and dependence to benzodiazepines in medical and nonmedical populations. American Journal on Drug and Alcohol Abuse 1991; 17: 27–37
   PubMed Web of Science ®Google Scholar
• Barker M, Greenwood K, Jackson M, Crowe S. Persistence of cognitive effects after withdrawal from long term benzodiazepine use: a meta-analysis. Archives of Clinical Neuropsychology 2004; 19: 437–454
   PubMed Web of Science ®Google Scholar
• Bailey L, Ward M, Musa M. Clinical pharmacokinetics of benzodiazepines. Journal of Clinical Pharmacology 1994; 34: 804–811
   PubMed Web of Science ®Google Scholar
• Schedule of Pharmaceutical Benefits, August, 2006; Psycholeptics; Alpazolam.
   Google Scholar
• Barsky A, Delamater B, Orav J. Panic disorder patients and their medical care. Psychosomatics 1999; 40: 50–56
   PubMed Web of Science ®Google Scholar
• Fifer S, Mathias S, Patrick D, Mazonson P, Lubeck D, Buesching D. Untreated anxiety among adult primary care patients in a health maintenance organization. Archives of General Psychiatry 1994; 51: 740–750
   PubMed Web of Science ®Google Scholar
• Weissman M, Klerman G, Markowitz J, Ouellette R. Suicidal ideation and suicide attempts in panic disorder and attacks. New England Journal of Medicine 1989; 321: 1209–1214
   PubMed Web of Science ®Google Scholar
• Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for Panic Disorder and Agoraphobia. Australia and New Zealand Clinical Practice Guidelines for the Treatment of Panic Disorder and Agoraphobia. Australian and New Zealand Journal of Psychiatry 2003; 37: 641–656
   PubMed Web of Science ®Google Scholar
• Bruce S, Vasile R, Goisman R, Tzanis E. Are Benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia?. American Journal of Psychiatry 2003; 160: 1432–1438
   PubMed Web of Science ®Google Scholar
• Tesar G, Rosenbaum J, Pollack M, et al. Double-blind, placebo controlled comparison of clonazepam and alprazolam for panic disorder. Journal of Clinical Psychiatry 1991; 52: 69–76
   PubMed Web of Science ®Google Scholar
• Noyes R, Burrows G, Reich J, et al. Diazepam versus alprazolam for the treatment of panic disorder. Journal of Clinical Psychiatry 1996; 57: 349–355
   PubMed Web of Science ®Google Scholar
• Darke S, Swift W, Hall W, Ross J. Drug use, HIV risk-taking and psychosocial correlates of benzodiazepine use among methadone maintenance clients. Drug and Alcohol Dependence 1993; 34: 67–70
   PubMed Web of Science ®Google Scholar
• Kerr T, Fairbairn N, Tyndall M, et al. Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug and Alcohol Dependence 2007; 87: 39–45
   PubMed Web of Science ®Google Scholar
• Fry C, Bruno R. Recent trends in benzodiazepine use by injecting drug users in Victoria and Tasmania. Drug and Alcohol Review 2002; 21: 363–367
   PubMed Web of Science ®Google Scholar
• Ross J, Darke S, Hall W. Transitions between routes of benzodiazepine administration among heroin users in Sydney. Addiction 1997; 92: 697–705
   PubMed Web of Science ®Google Scholar
• Dobbin M. Association of benzodiazepine injection with the prescription of temazepam capsules. Drug and Alcohol Review 2003; 22: 153–157
   PubMed Web of Science ®Google Scholar
• Eddey DP, Westcott MJ. The needle and the damage done’: inter-arterial temazepam. Emergency Medicine 2000; 12: 248–252
   Google Scholar
• Gilhooly T. Reduction in use of temazepam is a factor in deaths related to overdose. British Medical Journal 1997; 315: 1463–1464
   PubMed Web of Science ®Google Scholar
• Breen C, Degenhardt L, Bruno R, et al. The effects of restricting publicly subsidized temazepam capsules on benzodiazepine use among injecting drug users in Australia. Medical Journal of Australia 2004; 181: 300–304
   PubMed Web of Science ®Google Scholar
• Black, E, Roxburgh, A, Degenhardt, L, , et al. Australian Drug Trends 2007: Findings from the Illicit Drug Reporting System (IDRS), Australian Drug Trends Series No. 1. Sydney: National Drug and Alcohol Research Centre, University of New South Wales, 2008.
   Google Scholar
• Degenhardt L, Roxburgh A, van Beek I, et al. The effects of the market withdrawal of temazepam gel capsules on benzodiazepine injecting in Sydney, Australia. Drug and Alcohol Review 2008; 27: 145–151
   PubMed Web of Science ®Google Scholar
• de Graaff, B, Bruno, R. Tasmanian Drug Trends 2007: Findings from the Illicit Drug Reporting System (IDRS), Australian Drug Trends Series No. 5. Sydney: National Drug and Alcohol Research Centre, University of New South Wales,. 2008.
   Google Scholar
• Galloway J. New Restrictions on the Prescribing of Alprazolam. Information Circular for Pharmacists in Tasmania, No. 42. Department of Health and Human Services, Tasmania 2007
   Google Scholar
• Charles J, Britt H, Valenti L. The independent effect of age of general practitioner on clinical practice. Medical Journal of Australia 2006; 185: 105–109
   PubMed Web of Science ®Google Scholar
• Schectman J, Kanwal N, Schroth W, Elinsky E. The effect of an education and feedback intervention on group-model and network model health maintenance organization and physician prescribing behaviour. Medical Care 1995; 33: 139–144
   PubMed Web of Science ®Google Scholar
• Cockburn J, Pit S. Prescribing behaviour in clinical practice: patients’ expectations and doctors’ perception of patients’ expectations – a questionnaire study. British Medical Journal 1997; 315: 520–523
   PubMed Web of Science ®Google Scholar
• Greco P, Eisenberg J. Changing physicians’ practices. New England Journal of Medicine 1993; 329: 1271–1274
   PubMed Web of Science ®Google Scholar
• Davis D, Thompson M, Oxman A, Haynes R. Changing physician performance. A systematic review of the effect of CME strategies. Journal of the American Medical Association 1995; 274: 700–705
   PubMed Web of Science ®Google Scholar
• Grol R. Personal paper: Beliefs and evidence in changing clinical practice. British Medical Journal 1997; 315: 418–421
   PubMed Web of Science ®Google Scholar
• Sondergaard J, Hansen D, Aarslev P, Munck A. A multifaceted intervention according to the Audit Project Odense method improved secondary prevention of ischaemic heart disease: a randomised controlled trial. Family Practice 2006; 23: 198–202
   PubMed Web of Science ®Google Scholar